Reproductive Health

These risks were observed to become higher as gestational age decreased.

Postpartum depression (PPD) rates also had notable increases in those with class I and class II/III obesity.

Investigators also found that vaccination for those aged 27 to 45 produces a higher number needed to vaccinate.

Women aged 40 to 44 years at the time of natural menopause showed about a 30% decreased risk for asthma incidence.

Community pharmacists are playing an increasing role in sexual and reproductive health services and can provide that trustworthy information to patients.

The study found that this patient population was about 25% more likely to have serious mental health issues after childbirth.

Pregnancy rtes show similarity across the different glucagon-like peptide-1 (GLP-1) medications that were prescribed.

The authors note that exercise beyond 3 times per week was not associated with a lower risk of asthma, and more research is needed to confirm this finding.

Nationally, 7 million women live in maternal health deserts, defined as counties with limited or no available obstetric care.

In postmenopausal women, the gel can reduce moderate to severe hot flashes as well as menopausal changes and symptoms.

There are gonadotoxic risks of chemotherapy, radiation, and surgery that are important to discuss with patients.

Awareness of uterine fibroids and uterine fibroid embolization can prevent unnecessary hysterectomies, especially in Black women, who are more likely to have uterine fibroids.

Knowing the benefits and effects of norgestrel can assist pharmacists when counseling patients.

The highest pre-term birth rates were consistently observed among those who were Black, American Indian or Alaska Native, or Native Hawaiian or other Pacific islander with public insurance.

Research showed that children born via assisted reproductive technology were 36% more likely to develop heart defects.

As of now, data suggest minimal risk of drug interactions between oral contraceptives and injectable semaglutide.

The findings support current recommendations for pregnant individuals or those who might become pregnant during the influenza season, specifically those with successive pregnancies.

The survey demonstrated that adolescents and young adults (AYAs) who preferred health care professionals (HCPs) as sources of information had sufficient knowledge of contraception options available.

About 72% of the observed pregnancies after allogeneic hematopoietic cell transplantation occurred spontaneously, whereas remaining pregnancies were a result of assisted reproductive activities.

The researchers estimate that pregnancy losses because of malaria and parasitemia risk before conception was reduced by 65% to 86%.

The authors also found that there was a higher frequency of miscarriages compared with women who did not have asthma.

Additionally, the authors are concerned by the lack of increase in depressive or anxiety diagnoses, indicating potential barriers to care.

Intravenous immunoglobulin (IVIG) therapy was found to have statistically significant positive effects on live birth rates, implantation rate, and other indicators.

The findings demonstrate a need for additional health care provider training and resources for birthing people with intellectual and developmental disabilities.

Nurx reproductive access survey reveals 28% of women do not believe their right to contraception is protected.

Pharmacists play an important role in managing patients with this complex condition.

The use of CGMs in pregnancy provides clinicians with essential data in real-time, rather than a snapshot given by traditional finger stick testing.

Zuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.

Monitoring OTC sales, dispensing contraceptives, and prescribing birth controls drives a need in policy changes to adapt to increases in pharmacist workload.

An extension of a long-acting cabotegravir study shows safety prior to and during pregnancy in cisgender women, with full results being presented at the 2024 International AIDS Conference.